Sort   by:  
 Page size 
UnknownInherited determinants of Crohn's disease and ulcerative colitis phenotypes: a genetic association study.
Not available
S-EPMC4714968 | biostudies-literature
UnknownHost-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.
Not available
S-EPMC3491803 | biostudies-literature
UnknownHLA-DP on Epithelial Cells Enables Tissue Damage by NKp44<sup>+</sup> Natural Killer Cells in Ulcerative Colitis.
Not available
S-EPMC10529779 | biostudies-literature
UnknownDescription and Cross-Sectional Analyses of 25,880 Adults and Children in the UK National Registry of Rare Kidney Diseases Cohort.
Not available
S-EPMC11284373 | biostudies-literature
UnknownEffects of rare kidney diseases on kidney failure: a longitudinal analysis of the UK National Registry of Rare Kidney Diseases (RaDaR) cohort.
Not available
S-EPMC11750427 | biostudies-literature
UnknownA catalog of genetic loci associated with kidney function from analyses of a million individuals.
Not available
S-EPMC6698888 | biostudies-literature
UnknownGlobal, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.
Not available
S-EPMC4202387 | biostudies-literature
UnknownTocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8084355 | biostudies-literature
UnknownConvalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial.
Not available
S-EPMC8121538 | biostudies-literature
UnknownCasirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904 | biostudies-literature
Sort   by:  
 Page size